IFS
DGX icon

Ifrah Financial Services’s Quest Diagnostics DGX Stock Holding History

Ifrah Financial Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,987
Closed -$221K – 197
2017
Q2 		$221K Buy
+1,987
New +$210K 0.09% 173

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ifrah Financial Services's DGX Position: Q3 2017 in Review

Ifrah Financial Services sold out of Quest Diagnostics (DGX) in Q3 2017, closing a stake of 1,987 shares — an estimated $221K sold.

Ifrah Financial Services first reported a position in DGX in Q2 2017 and held it in 1 quarter. The position peaked at $221K in Q2 2017. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

  • Ifrah Financial Services reported no remaining Quest Diagnostics position as of Q3 2017 after selling out during the quarter.
  • Ifrah Financial Services sold 1,987 Quest Diagnostics shares in Q3 2017, an estimated $221K.
  • Ifrah Financial Services first reported a position in Quest Diagnostics in Q2 2017 and held it in 1 quarter.
  • Ifrah Financial Services's Quest Diagnostics position peaked at $221K in Q2 2017.
  • 616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on Ifrah Financial Services's 13F filing for Q3 2017, filed 6 Nov 2017.